Accelerant (ARX) Q2 2026 earnings review
Thoma Bravo Take-Private Validates Capital-Light Strategy
Accelerant is being acquired by Thoma Bravo for $20.25 per share in cash, a 49% premium valuing the company at over $4 billion. The Q2 results perfectly illustrate why private equity swooped in: the company's shift to a capital-light, fee-based model is accelerating. Exchange Written Premium (EWP) grew 23% YoY to $1.32 billion, while the portion ceded to third-party insurers jumped to 47% (up from 27% a year ago). This mix shift drove Adjusted EBITDA up 46% to $93.1M. However, plunging Net Revenue Retention (111% vs 151% last year) suggests organic growth from existing members is rapidly cooling, making a take-private exit at a massive premium a definitive win for current shareholders.
🐂 Bull Case
The $20.25 all-cash offer delivers immediate, guaranteed upside. The 49% premium over the prior close protects investors from any future macroeconomic or cycle-driven downside.
Adjusted EBITDA margins expanded to 31% from 29% a year ago. The company proved it can successfully offload balance sheet risk (47% third-party premium) while expanding fee-based earnings.
🐻 Bear Case
Net Revenue Retention crashed to 111% from 151% a year ago. The core narrative of 'embedded organic growth' is cracking, which likely motivated management to lock in a sale now.
The transaction isn't expected to close until H1 2027. While there is a 6% ticking fee if insurance regulatory approvals cause delays, a 6 to 12-month wait introduces meaningful closing risk.
⚖️ Verdict: 🟢🟢
Bullish. The operational metrics are solid, but the only thing that matters today is the 49% cash premium. Management executed their capital-light transition just well enough to sell the infrastructure narrative to Thoma Bravo before decelerating retention rates became a public market liability.
Key Themes
Capital-Light Transformation Hits Target
Accelerating. The strategy to move risk off Accelerant's balance sheet is succeeding wildly. Third-party direct written premium accounted for 47% of total volume, up drastically from 27% a year ago. This mix shift directly translates to higher-quality, fee-based operating revenue, which surged 39% YoY to $303.9 million.
AI 'ARC' Agent Deployment
Accelerating. Accelerant continues to lean into its tech-stack differentiation, introducing a new AI agent named ARC. ARC serves as a 'front door' to instantly recognize, classify, and structure inbound data. This technological edge is exactly what Thoma Bravo (a software-focused PE firm) is paying a premium to acquire, as it reduces onboarding friction and administrative costs.
The Hidden Weakness: Plunging Net Revenue Retention
Decelerating. Behind the headline beats lies a glaring contradiction to management's historical 'organic growth machine' claims. Net Revenue Retention fell to 111% in Q2 2026, down continuously from 116% in Q1 2026, 126% in Q4 2025, and 151% in Q2 2025. Existing MGAs are dramatically slowing their growth on the platform. If this business were staying public, this would trigger a massive sell-off.
Extended Regulatory Timeline Risk
Stable. The Thoma Bravo acquisition is slated to close in the 'first half of 2027.' In the M&A world, a 6 to 12-month window for insurance regulatory approvals across 22 countries leaves significant room for macro or regulatory disruptions. A 6% ticking fee softens the blow for shareholders, but the closing risk is real.
Private Equity Validates the MGA Ecosystem
Macro development. Thoma Bravo's $4B+ entry signals that the specialty MGA market has matured into an infrastructure play. Thoma Bravo recognized that Accelerant functions more like a high-margin enterprise SaaS routing system (matching risk to capital) than a traditional balance-sheet insurer.
Gross Loss Ratio Tick-Up
Reversing. The gross loss ratio increased to 52.0% from 50.5% in the prior year quarter. While management has consistently guided for the 'low 50s,' this slight deterioration warrants monitoring by the incoming private owners to ensure the AI underwriting models are maintaining discipline amidst high top-line growth.
Aggressive Buybacks Pre-Deal
Stable. The company executed beautifully on capital returns right before the buzzer. Accelerant repurchased 4.7 million shares for $66 million in the quarter. By shrinking the float before a fixed-price buyout, they mathematically maximized value for remaining shareholders.
Other KPIs
Accelerating. Up 165% from $26.4 million a year ago. This massive jump showcases the operating leverage of the platform. As more premium shifts to third-party paper, the associated fee income drops directly to the bottom line without the drag of reserving requirements.
Decelerating. While up 23% YoY, this compares to a 42% YoY growth rate in the same quarter last year (25Q2). The sheer scale of the $4.6B trailing-twelve-month base makes maintaining hyper-growth difficult, cementing the logic of the buyout.
Guidance
Reversing. Due to the pending acquisition by Thoma Bravo, Accelerant has officially canceled its earnings call and withdrawn all prior financial guidance for Q3 and the full year 2026. The stock will now trade strictly on the deal dynamics and the $20.25 cash offer, rendering fundamental forward estimates obsolete.
Key Questions
Regulatory Hurdles
Given the target closing date stretches into H1 2027, what specific geographic jurisdictions or insurance regulators pose the highest risk of delaying or blocking the transaction?
Hadron De-concentration Strategy
Under Thoma Bravo's private ownership, will the previous mandate to aggressively reduce reliance on the Hadron capacity relationship continue, or does PE ownership change the risk-capital strategy?
Management Retention
With the founders and Altamont retaining some equity, what are the specific lock-up or earn-out structures ensuring the executive team stays to execute the AI roadmap post-close?